The combined use of antiplatelet drugs acting through different mechanisms is important in antithrombotic treatment of patients with cardiovascular disease. The improvement of our knowledge on the ...

The risk for recurrent cardiovascular events is high among patients with r-axSpA and a history of these events, though TNF inhibitor therapy may offer protective benefits.

A primary benefit of abbreviated antiplatelet therapy is a significant ... Careful risk assessment and tailored treatment strategies are crucial. “[Diabetes mellitus] remains an independent ...

This country research report on Vietnam Atherosclerosis Drugs Market offers comprehensive insights into the market landscape, customer intelligence, and competitive strategies in the Vietnam market.

Surviving a severe case of COVID-19 may be just as dangerous for your heart as having cardiovascular disease - even if you were perfectly healthy before infection.

Chronic Subdural Hematoma (cSDH) presents a growing challenge in the field of neurosurgery, with particular significance in elderly populations. Projected ...

Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China (Y.Z., X.W., Y.G., W.C., H.Y., T.W., Y.Y., Q.Z., M.W., J.J., C.W., Yongjun Wang ...

While aspirin is traditionally the standard antiplatelet agent ... No significant interaction was observed between treatment effects and the presence of HBR or PCI complexity, indicating that ...

Background While dual antiplatelet therapy (dAPT ... to identify patients receiving carotid endarterectomy (CEA) or CAS for treatment of ischemic stroke or carotid artery stenosis from 2007 to 2016.

The ARIES-HM3 trial analysis found that in advanced heart failure patients with traditional indications for antiplatelet ...

The family then hired a lawyer whose investigation found red flag after red flag associated with Integrity Wellness, the clinic where Ray sought treatment ... trial for the antiplatelet drug ...